19-18444858-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000262809.9(ELL):āc.1760A>Gā(p.Asn587Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000269 in 1,611,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000262809.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELL | NM_006532.4 | c.1760A>G | p.Asn587Ser | missense_variant | 12/12 | ENST00000262809.9 | NP_006523.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELL | ENST00000262809.9 | c.1760A>G | p.Asn587Ser | missense_variant | 12/12 | 1 | NM_006532.4 | ENSP00000262809 | P1 | |
ELL | ENST00000596124.3 | c.1361A>G | p.Asn454Ser | missense_variant | 12/12 | 1 | ENSP00000475648 | |||
ELL | ENST00000594635.6 | c.*1595A>G | 3_prime_UTR_variant, NMD_transcript_variant | 13/13 | 1 | ENSP00000475681 | ||||
ELL | ENST00000610152.1 | n.187A>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000192 AC: 48AN: 249642Hom.: 0 AF XY: 0.000163 AC XY: 22AN XY: 135246
GnomAD4 exome AF: 0.000283 AC: 413AN: 1459304Hom.: 0 Cov.: 31 AF XY: 0.000271 AC XY: 197AN XY: 726010
GnomAD4 genome AF: 0.000131 AC: 20AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | The c.1760A>G (p.N587S) alteration is located in exon 12 (coding exon 12) of the ELL gene. This alteration results from a A to G substitution at nucleotide position 1760, causing the asparagine (N) at amino acid position 587 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at